The Role of Cellular Senescence in Health, Disease, and Aging
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Aging".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 6535
Special Issue Editor
Interests: cancer; cell cycle; cellular senescence; endoplasmic reticulum stress; molecular target drugs; p53; transcriptional regulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the human population ages, people are faced with various health challenges brought on by old age. The concept of the senescence of an individual is also gaining acceptance as a result of the greater understanding of the senescence of the cells that make up the organism. Senescence research has been a very active field in recent years, as the role of aging in disease and physiological processes has become clearer and as aging-based therapeutic interventions have become more promising. In particular, the extension of human life spans via the removal of senescent cells must be seen as an epoch-making event. These groundbreaking matters are produced through the accumulation of deep basic research and the challenge of clinical application on cellular senescence.
This Special Issue provides an open access forum to compile a collection of original research and review articles on the role of cellular senescence in health, disease and aging. We welcome submissions on a wide range of research topics, including molecular mechanisms of cellular senescence and the pathogenesis of diseases such as cancer and age-related diseases caused by cellular senescence.
Dr. Yasumichi Inoue
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- apoptosis
- cancer
- cell cycle
- DNA damage
- metabolic diseases
- oxidative stress
- senolysis
- senescence
- therapeutic approach
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.